$SCPX
Scorpius Holdings, Inc. Stock $scpx

$scpx Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-K Financial Statement

#000155335014000314 Filed on March 31, 2014

Income Statement

Concept	2014 Q1	2013 Q1	2013
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.010M	$270.0K	$2.565M
YoY Change	274.07%	17.39%	114.55%
% of Gross Profit
Research & Development	$533.6K	$440.3K	$2.738M
YoY Change	21.2%	158.99%	203.2%
% of Gross Profit
Depreciation & Amortization	$2.170K	$814.00	$6.348K
YoY Change	166.58%		145.38%
% of Gross Profit
Operating Expenses	$2.395M	$770.5K	$6.565M
YoY Change	210.83%	75.11%	179.85%
Operating Profit	-$2.395M	-$770.5K	-$6.565M
YoY Change	210.83%		180.22%
Interest Expense		$28.34K	$79.12K
YoY Change			-21.73%
% of Operating Profit
Other Income/Expense, Net	-$28.08K	-$17.98K	-$45.22K
YoY Change	56.2%		-58.26%
Pretax Income	-$2.420M	-$790.0K	-$6.610M
YoY Change	206.33%	75.56%	169.8%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$2.331M	-$3.064M	-$9.073M
YoY Change	-23.93%	596.33%	274.89%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$25.88	-$102.00	-$181.40
COMMON SHARES
Basic Shares Outstanding	6.452M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q1	2013 Q1	2013
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.40M	$4.900M	$21.90M
YoY Change	295.92%
Cash & Equivalents	$2.690M	$4.890M	$4.600M
Short-Term Investments	$16.70M		$17.30M
Other Short-Term Assets	$900.0K	$200.0K	$1.100M
YoY Change	350.0%		1000.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$20.33M	$5.100M	$23.00M
YoY Change	298.68%		22900.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$56.74K	$0.00	$100.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.57K	$100.0K	$0.00
YoY Change	-89.43%		-100.0%
Total Long-Term Assets	$67.31K	$100.0K	$0.00
YoY Change	-32.69%
TOTAL ASSETS
Total Short-Term Assets	$20.33M	$5.100M	$23.00M
Total Long-Term Assets	$67.31K	$100.0K	$0.00
Total Assets	$20.40M	$5.200M	$23.00M
YoY Change	292.31%		22900.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$378.4K	$1.100M	$700.0K
YoY Change	-65.6%		16.67%
Accrued Expenses	$378.5K	$0.00	$500.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$300.0K
YoY Change
Total Short-Term Liabilities	$756.9K	$1.400M	$1.200M
YoY Change	-45.94%		71.43%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$1.100M	$0.00
YoY Change	-100.0%		-100.0%
Other Long-Term Liabilities		$100.0K	$100.0K
YoY Change			0.0%
Total Long-Term Liabilities	$0.00	$1.200M	$100.0K
YoY Change	-100.0%		-90.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$756.9K	$1.400M	$1.200M
Total Long-Term Liabilities	$0.00	$1.200M	$100.0K
Total Liabilities	$756.9K	$2.400M	$1.000M
YoY Change	-68.46%		-37.5%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$975.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.01M	$2.700M	$22.00M
YoY Change
Total Liabilities & Shareholders Equity	$20.40M	$5.200M	$23.00M
YoY Change	292.31%		22900.0%

Cashflow Statement

Concept	2014 Q1	2013 Q1	2013
OPERATING ACTIVITIES
Net Income	-$2.331M	-$3.064M	-$9.073M
YoY Change	-23.93%	596.33%	274.89%
Depreciation, Depletion And Amortization	$2.170K	$814.00	$6.348K
YoY Change	166.58%		145.38%
Cash From Operating Activities	-$2.391M	-$504.1K	-$6.389M
YoY Change	374.33%	14.56%	208.09%
INVESTING ACTIVITIES
Capital Expenditures	$5.155K		$49.32K
YoY Change			2670.73%
Acquisitions
YoY Change
Other Investing Activities	$480.0K	$0.00	-$17.35M
YoY Change
Cash From Investing Activities	$477.5K		-$17.40M
YoY Change			977274.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00	$540.00
YoY Change		-100.0%	-95.23%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$36.73K	$5.389M	$28.35M
YoY Change	-99.32%	1281.74%	1330.39%
NET CHANGE
Cash From Operating Activities	-$2.391M	-$504.1K	-$6.389M
Cash From Investing Activities	$477.5K		-$17.40M
Cash From Financing Activities	$36.73K	$5.389M	$28.35M
Net Change In Cash	-$1.877M	$4.885M	$4.562M
YoY Change	-138.42%	-9869.39%	-4973.06%
FREE CASH FLOW
Cash From Operating Activities	-$2.391M	-$504.1K	-$6.389M
Capital Expenditures	$5.155K		$49.32K
Free Cash Flow	-$2.396M	-$504.1K	-$6.438M
YoY Change	375.35%	14.56%	210.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001476963
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6452341	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2014Q1	dei	Entity Public Float EntityPublicFloat	29384995	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	HEAT BIOLOGICS, INC.
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2009Q2	htbx	Additional Consideration AdditionalConsideration	12500	USD
CY2013	htbx	Amortization On Bond Premium AmortizationOnBondPremium	50781	USD
CY2012	htbx	Amortization On Bond Premium AmortizationOnBondPremium		USD
	htbx	Amortization On Bond Premium AmortizationOnBondPremium	50781	USD
CY2013	htbx	Cancellation Of Common Stock CancellationOfCommonStock		USD
CY2012	htbx	Cancellation Of Common Stock CancellationOfCommonStock		USD
	htbx	Cancellation Of Common Stock CancellationOfCommonStock	65	USD
CY2013	htbx	Capitalized Costs Property And Equipment CapitalizedCostsPropertyAndEquipment	500	USD
CY2013	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	1397157	USD
CY2012	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	253189	USD
	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	1825000	USD
CY2013Q4	htbx	Common Stock Fair Value Per Share CommonStockFairValuePerShare	8.81
CY2009Q2	htbx	Future Minimum Royalty Payments Remainder Life Of Agreement FutureMinimumRoyaltyPaymentsRemainderLifeOfAgreement	20000	USD
CY2009Q2	htbx	Future Minimum Royalty Payments Three Years Amount FutureMinimumRoyaltyPaymentsThreeYearsAmount	10000	USD
CY2013	htbx	Issuance Of Preferred Stock Warrants Including Debt Issuance Costs IssuanceOfPreferredStockWarrantsIncludingDebtIssuanceCosts		USD
CY2012	htbx	Issuance Of Preferred Stock Warrants Including Debt Issuance Costs IssuanceOfPreferredStockWarrantsIncludingDebtIssuanceCosts	31680	USD
CY2013Q4	htbx	Effective Conversion Price Per Share EffectiveConversionPricePerShare	6.14
CY2013Q4	htbx	Future Minimum Royalty Payments Due FutureMinimumRoyaltyPaymentsDue	520000	USD
CY2013Q4	htbx	Future Minimum Royalty Payments Due Current FutureMinimumRoyaltyPaymentsDueCurrent	30000	USD
CY2013Q4	htbx	Future Minimum Royalty Payments Due In Five Years FutureMinimumRoyaltyPaymentsDueInFiveYears	30000	USD
CY2013Q4	htbx	Future Minimum Royalty Payments Due In Four Years FutureMinimumRoyaltyPaymentsDueInFourYears	280000	USD
CY2013Q4	htbx	Future Minimum Royalty Payments Due In Three Years FutureMinimumRoyaltyPaymentsDueInThreeYears	30000	USD
CY2013Q4	htbx	Future Minimum Royalty Payments Due In Two Years FutureMinimumRoyaltyPaymentsDueInTwoYears	30000	USD
CY2013Q4	htbx	Future Minimum Royalty Payments Due Thereafter FutureMinimumRoyaltyPaymentsDueThereafter	120000	USD
	htbx	Issuance Of Preferred Stock Warrants Including Debt Issuance Costs IssuanceOfPreferredStockWarrantsIncludingDebtIssuanceCosts	87570	USD
CY2011Q4	htbx	Lease Agreement Term LeaseAgreementTerm	P13M
CY2017Q2	htbx	Milestone Payment MilestonePayment	250000	USD
CY2022Q1	htbx	Milestone Payment MilestonePayment	400000	USD
CY2013Q4	htbx	Minimum Cash Balance To Pay Trademark Fees MinimumCashBalanceToPayTrademarkFees	1000	USD
CY2013Q4	htbx	Minimum Cash Balance With Lending Bank MinimumCashBalanceWithLendingBank	25000	USD
CY2012Q2	htbx	Minority Interest Ownership Price Per Share MinorityInterestOwnershipPricePerShare	0.0025
CY2013Q4	htbx	Miscellaneous Expenses MiscellaneousExpenses	106462	USD
CY2012Q4	htbx	Miscellaneous Expenses MiscellaneousExpenses	3281	USD
CY2013	htbx	Non Cash Consideration For Rent NonCashConsiderationForRent		USD
CY2012	htbx	Non Cash Consideration For Rent NonCashConsiderationForRent		USD
	htbx	Non Cash Consideration For Rent NonCashConsiderationForRent	15624	USD
CY2013	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock	386	USD
CY2012	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock		USD
	htbx	Non Cash Conversion Of Preferred Stock Into Common Stock NonCashConversionOfPreferredStockIntoCommonStock	386	USD
CY2010Q3	htbx	Option Fees OptionFees	2000	USD
CY2013	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	5050090	USD
CY2012	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	100000	USD
CY2011	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	154255	USD
CY2009	htbx	Preferred Stock Issued During Period Value Issued For Cash PreferredStockIssuedDuringPeriodValueIssuedForCash	250000	USD
CY2012	htbx	Preferred Stock Issued During Period Value Issued For Cash Transaction Three PreferredStockIssuedDuringPeriodValueIssuedForCashTransactionThree	900000	USD
CY2012	htbx	Preferred Stock Issued During Period Value Issued For Cash Transaction Two PreferredStockIssuedDuringPeriodValueIssuedForCashTransactionTwo	83334	USD
CY2013Q4	htbx	Preferred Stock Redemption Public Offering Net Proceeds Threshold PreferredStockRedemptionPublicOfferingNetProceedsThreshold	15000000	USD
CY2013	htbx	Proceeds From Issuance Initial Public Offering Gross ProceedsFromIssuanceInitialPublicOfferingGross	27000000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Gross ProceedsFromIssuanceInitialPublicOfferingGross	25000000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Gross ProceedsFromIssuanceInitialPublicOfferingGross	1000000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Gross ProceedsFromIssuanceInitialPublicOfferingGross	1000000	USD
CY2013	htbx	Proceeds From Issuance Initial Public Offering Net ProceedsFromIssuanceInitialPublicOfferingNet	24300000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Net ProceedsFromIssuanceInitialPublicOfferingNet	22400000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Net ProceedsFromIssuanceInitialPublicOfferingNet	930000	USD
CY2013Q3	htbx	Proceeds From Issuance Initial Public Offering Net ProceedsFromIssuanceInitialPublicOfferingNet	930000	USD
CY2012Q2	htbx	Proceeds From Sale Of Subsidiary ProceedsFromSaleOfSubsidiary	9250	USD
CY2012Q2	htbx	Receivable Amount By Sale Of Subsidiary ReceivableAmountBySaleOfSubsidiary	296224	USD
CY2010Q4	htbx	Reimbursement Of For Past Patent Fees ReimbursementOfForPastPatentFees	15797	USD
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction One StockIssuedDuringPeriodValueConversionOfSharesTransactionOne		USD
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction Three StockIssuedDuringPeriodValueConversionOfSharesTransactionThree		USD
CY2013	htbx	Stock Issued During Period Value Conversion Of Shares Transaction Two StockIssuedDuringPeriodValueConversionOfSharesTransactionTwo		USD
CY2009	htbx	Stock Issued During Period Value Issued For Cash Transaction Three StockIssuedDuringPeriodValueIssuedForCashTransactionThree	23	USD
	htbx	Stock Issued During Period Value Issued For Cash Transaction Three StockIssuedDuringPeriodValueIssuedForCashTransactionThree	42	USD
CY2012	htbx	Stock Issued During Period Value Issued For Cash Transaction Two StockIssuedDuringPeriodValueIssuedForCashTransactionTwo	10500	USD
CY2009	htbx	Stock Issued During Period Value Issued For Cash Transaction Two StockIssuedDuringPeriodValueIssuedForCashTransactionTwo	5	USD
	htbx	Stock Issued During Period Value Issued For Cash Transaction Two StockIssuedDuringPeriodValueIssuedForCashTransactionTwo	60	USD
CY2011Q4	htbx	Unpaid License Fees UnpaidLicenseFees	160000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	651917	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	505471	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	503050	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	129208	USD
CY2013Q4	us-gaap	Accumulated Amortization Of Current Deferred Finance Costs AccumulatedAmortizationOfCurrentDeferredFinanceCosts		USD
CY2012Q4	us-gaap	Accumulated Amortization Of Current Deferred Finance Costs AccumulatedAmortizationOfCurrentDeferredFinanceCosts	3451	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9559	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3211	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34337591	USD
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4495832	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	571924	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	217896	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	91984	USD
CY2009	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13364	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30791	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	-944478	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	-22419	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	-17581	USD
CY2010	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	-7584	USD
CY2013	us-gaap	Advertising Cost Policy Expensed Advertising Cost AdvertisingCostPolicyExpensedAdvertisingCost	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0px; text-align: justify"> <strong><em>Marketing</em></strong></p> <p style="MARGIN: 0px; text-align: justify"><br /> </p> <p style="MARGIN: 0px">Marketing costs are expensed as incurred. Marketing expense totaled $135,366 and $5,921 for the years ended December 31, 2013 and 2012, respectively. Marketing expenses from inception through December 31, 2013 totaled $183,274.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	28229	USD
CY2012	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	58458	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	126742	USD
CY2013Q4	us-gaap	Assets Assets	23020066	USD
CY2012Q4	us-gaap	Assets Assets	147582	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	22955741	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	73037	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4566992	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5030	USD
CY2008Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	98646	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4561962	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-93616	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4566992	USD
CY2013Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
CY2013Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	4046451	USD
CY2013	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	36167	shares
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6375426	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2144542	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6375426	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1858971	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	961	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	405	USD
CY2013	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="MARGIN: 0px"><strong><em>Concentration of Credit Risk</em></strong></p> <p style="MARGIN: 0px"><br /> </p> <p style="MARGIN: 0px">At times, cash balances may exceed the Federal Deposit Insurance Corporation ("FDIC") insurable limits. The Company has never experienced any losses related to these balances. All of the Company's cash balances were fully insured at December 31, 2012. As of December 31, 2013, cash amounts in excess of $250,000 were not fully insured. The uninsured cash balance as of December 31, 2013 was $4,046,451. The Company does not believe it is exposed to significant credit risk on cash and cash equivalents.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1696683	shares
CY2013Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		USD
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	197099	USD
CY2011Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	950000	USD
CY2013Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	0.4348	shares
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2013Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		USD
CY2013Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		USD
CY2013Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		USD
CY2011Q4	us-gaap	Debt Conversion Description DebtConversionDescription	The note is convertible into common or Series A preferred stock at the latest valuation. The type of security converted will depend on whether common or Series A preferred stock is issued as part of a successful future equity raise of at least $7.5 million at the qualified offering price.
CY2013	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	-2300000	USD
CY2012	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	-2300000	USD
CY2011Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	950000	USD
CY2013Q4	us-gaap	Debt Instrument Interest Rate At Period End DebtInstrumentInterestRateAtPeriodEnd	0.18	pure
CY2011Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2011Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2019-10-31
CY2012	us-gaap	Dividends Preferred Stock DividendsPreferredStock		USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	361668	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	50013	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		USD
CY2013Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		USD
CY2013Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet		USD
CY2012Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	28229	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		USD
CY2013Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		USD
CY2013Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	424739	USD
CY2012Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	189350	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4167785	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2186432	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	247966	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4840490	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2425795	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9320	USD
CY2012Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9320	USD
CY2013	us-gaap	Depreciation Depreciation	6348	USD
CY2012	us-gaap	Depreciation Depreciation	2587	USD
	us-gaap	Depreciation Depreciation	9559	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	12346630	USD
CY2012Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	5935282	USD
CY2013	us-gaap	Dividends Preferred Stock DividendsPreferredStock	361668	USD
CY2013Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	24946	USD
CY2012Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	9571	USD
CY2013Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	13000	USD
CY2012Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent		USD
CY2013	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.42
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.32
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	356588	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	105927	USD
CY2013	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P14M
CY2013Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1604200	USD
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	30440	USD
CY2012	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	3540	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	35020	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	30440	USD
CY2013	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues		USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	122590	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	92150	USD
CY2012	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2451018	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-12332683	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity		USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-20129	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-288724	USD
CY2013	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-6609864	USD
CY2012	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-2471147	USD
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-12621407	USD
CY2011	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-2113142	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49319	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2429796	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1189660	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4725322	USD
CY2013Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	17297165	USD
CY2012Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent		USD
CY2013	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-6609864	USD
CY2009	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-423439	USD
	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-281971	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		USD
CY2013	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2414695	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1099968	USD
CY2013	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	32774	USD
CY2012	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		USD
CY2013	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2247353	USD
CY2012	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-840190	USD
CY2013Q4	us-gaap	Notes Payable Current NotesPayableCurrent		USD
CY2013	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	373842	USD
CY2012	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	103307	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	503050	USD
CY2013	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		USD
CY2012	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	200	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-9320	USD
CY2013	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	15375	USD
CY2012	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	9571	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	24946	USD
CY2013	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	11601	USD
CY2012Q4	us-gaap	Notes Payable Current NotesPayableCurrent	66806	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	6564641	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	2345787	USD
	us-gaap	Operating Expenses OperatingExpenses	12645492	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-6564641	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-2342677	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12059903	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	4985	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	54991	USD
CY2013	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	-180687	USD
CY2012	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	-57293	USD
CY2013	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	162061	USD
CY2012	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-152306	USD
CY2013	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-186475	USD
CY2012	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-105170	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	146446	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	85323	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	651917	USD
CY2012	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	13077	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	76635	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1008202	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	52843	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1066638	USD
CY2013	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-24962	USD
CY2012	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	24502	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	1252	USD
CY2013	us-gaap	Interest Expense InterestExpense	79119	USD
CY2012	us-gaap	Interest Expense InterestExpense	101086	USD
	us-gaap	Interest Expense InterestExpense	298580	USD
CY2013	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10068	USD
CY2012	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10755	USD
CY2013	us-gaap	Interest Paid InterestPaid	60922	USD
CY2012	us-gaap	Interest Paid InterestPaid	29049	USD
	us-gaap	Interest Paid InterestPaid	135606	USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	25364	USD
CY2012Q4	us-gaap	Interest Payable Current InterestPayableCurrent	13763	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	10000	USD
CY2013Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	20999761	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	20000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10572	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	63763	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	122590	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	92150	USD
CY2013	us-gaap	Other Noncash Expense OtherNoncashExpense		USD
CY2012	us-gaap	Other Noncash Expense OtherNoncashExpense		USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	15624	USD
CY2013	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	48377	USD
CY2012	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	43341	USD
CY2011Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3870	USD
CY2012Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4046	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1302921	USD
CY2012Q4	us-gaap	Liabilities Liabilities	1662691	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23020066	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	147582	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1180331	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	715248	USD
CY2013Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		USD
CY2012Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	658194	USD
CY2013	us-gaap	Marketing Expense MarketingExpense	135366	USD
CY2012	us-gaap	Marketing Expense MarketingExpense	5921	USD
	us-gaap	Marketing Expense MarketingExpense	183274	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	274777	USD
CY2012Q4	us-gaap	Minority Interest MinorityInterest	76261	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28348095	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1981839	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33306526	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17397265	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1780	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17411258	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6388868	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2073675	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11328276	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-9073016	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-2420200	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15008298	USD
CY2013	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-198516	USD
CY2012	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-50947	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-274777	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-45223	USD
CY2012	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-108341	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-272780	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23828	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7257	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15045	USD
CY2013	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	944478	USD
CY2012	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	22419	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	992062	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1780	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	63312	USD
CY2013	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	17347946	USD
CY2012	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	17347946	USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	361668	USD
CY2012	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact		USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	361668	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1066638	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	58436	USD
CY2013	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	54042	USD
CY2011Q3	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000	USD
CY2012	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	197099	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2781636	USD
CY2013	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	25110000	USD
CY2012	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		USD
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	25110000	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	540	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11325	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	12330	USD
CY2013	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		USD
CY2012	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	273427	USD
CY2013	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	200000	USD
CY2012	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	950000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1150000	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	54042	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63312	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13993	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53753	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10782	USD
CY2013	us-gaap	Revenues Revenues		USD
CY2012	us-gaap	Revenues Revenues	3110	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	197099	USD
CY2013	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		USD
CY2012	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	273427	USD
CY2013	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	925000	USD
CY2012	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	225000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1150000	USD
	us-gaap	Revenues Revenues	585589	USD
CY2012Q2	us-gaap	Receivable With Imputed Interest Effective Yield Interest Rate ReceivableWithImputedInterestEffectiveYieldInterestRate	0.06	pure
CY2013	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	197099	USD
CY2012	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		USD
CY2013Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	725000	USD
CY2013	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		USD
CY2012	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	12500	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		USD
CY2013	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2737688	USD
CY2012	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	902938	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6095170	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1252	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	26214	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1252	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	26214	USD
CY2012Q2	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	0.925	pure
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.71
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.64
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	633482	shares
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	-334098	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	186736	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	178742	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	590047	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	471905	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.36
CY2008Q2	us-gaap	Stockholders Equity StockholdersEquity		USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.51
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.31
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	207059	shares
CY2012Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	158077	shares
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-1515109	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.71
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.64
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	426423	shares
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1438848	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	571924	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	217896	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	925959	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1500000	shares
CY2009Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	500000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	426423	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.23
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y3M22D
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	62595	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	37773	shares
CY2011Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	248439	shares
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	46734	shares
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	11594	shares
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	1.96
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	0.02
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.36
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.23
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y3M22D
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	440820	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	91020	shares
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	257510	shares
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.67
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.51
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.67
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.51
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.96
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.02
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	10.07
CY2012	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.76
CY2013	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	-277444	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	-431717	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	-1124594	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21991922	USD
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	633482	shares
CY2013Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.36
CY2013	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y3M7D
CY2008Q2	us-gaap	Shares Outstanding SharesOutstanding		shares
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	21717145	USD
CY2013	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4348	pure
CY2013Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	.4348
CY2013Q3	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	2500000	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	100000	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares Issued For Cash StockIssuedDuringPeriodSharesIssuedForCash	100000	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	80706	shares
CY2012	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	22827	shares
CY2011	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		USD
CY2013	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	25110540	USD
CY2012	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	825	USD
CY2009	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	14	USD
	us-gaap	Stock Issued During Period Value Issued For Cash StockIssuedDuringPeriodValueIssuedForCash	321	USD
CY2009	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	5760	USD
	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	4104	USD
CY2010	us-gaap	Stock Issued During Period Value Issued For Noncash Considerations StockIssuedDuringPeriodValueIssuedForNoncashConsiderations	5760	USD
CY2011	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2674980	USD
CY2013	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		USD
CY2012	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	54042	USD
CY2009	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue		USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="BACKGROUND-COLOR: #ffffff; MARGIN: 0px"><strong><em>Use of Estimates</em></strong></p> <p style="MARGIN: 0px; text-align: justify"><br /> </p> <p style="MARGIN: 0px">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are used for, but not limited to, useful lives of fixed assets, income taxes and stock-based compensation. Actual results may differ from those estimates.</p> <!--EndFragment--></div> </div>
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2414695	USD
CY2013	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3747357	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1831769	shares

Files In Submission

Name	View Source	Status
0001553350-14-000314-index-headers.html	Edgar Link	pending
0001553350-14-000314-index.html	Edgar Link	pending
0001553350-14-000314.txt	Edgar Link	pending
0001553350-14-000314-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
htbx-20131231.xml	Edgar Link	completed
htbx-20131231.xsd	Edgar Link	pending
htbx-20131231_cal.xml	Edgar Link	unprocessable
htbx-20131231_def.xml	Edgar Link	unprocessable
htbx-20131231_lab.xml	Edgar Link	unprocessable
htbx-20131231_pre.xml	Edgar Link	unprocessable
htbx_10k.htm	Edgar Link	pending
htbx_10k002.gif	Edgar Link	pending
htbx_10k004.gif	Edgar Link	pending
htbx_10k006.gif	Edgar Link	pending
htbx_ex10z39.htm	Edgar Link	pending
htbx_ex10z39003.gif	Edgar Link	pending
htbx_ex10z39004.gif	Edgar Link	pending
htbx_ex10z39005.jpg	Edgar Link	pending
htbx_ex10z39006.jpg	Edgar Link	pending
htbx_ex10z39007.jpg	Edgar Link	pending
htbx_ex10z39008.jpg	Edgar Link	pending
htbx_ex10z40.htm	Edgar Link	pending
htbx_ex21z1.htm	Edgar Link	pending
htbx_ex23z1.htm	Edgar Link	pending
htbx_ex31z1.htm	Edgar Link	pending
htbx_ex31z2.htm	Edgar Link	pending
htbx_ex32z1.htm	Edgar Link	pending
htbx_ex32z2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCPX
Scorpius Holdings, Inc. Stock $scpx

2014 Q1 Form 10-K Financial Statement

#000155335014000314 Filed on March 31, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX Scorpius Holdings, Inc. Stock $scpx

2014 Q1 Form 10-K Financial Statement

#000155335014000314 Filed on March 31, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX
Scorpius Holdings, Inc. Stock $scpx